HOME > BUSINESS
BUSINESS
- JCR’s Hunter Syndrome Drug Grabs FDA’s Orphan Status
October 22, 2018
- Eisai, Keio Univ. Identify Candidate Compound for Parkinson’s Disease Employing iPS Cells
October 22, 2018
- Prescribers Asked to Stop New Enbrel Biosimilar Use as Maker Can’t Keep Up with Demand
October 19, 2018
- Takeda Earns Japan Clearance for Shire Acquisition
October 19, 2018
- Asahi Kasei Obtains Patent License for iPS Cell-Derived Cartilage Regeneration Technology
October 18, 2018
- Sumitomo Dainippon to Invest in, Conduct Joint R&D with Cyborg Tech Startup
October 18, 2018
- Nippon Shinyaku Seeks Japan Approval for Hepatic VOD Treatment Defibrotide
October 18, 2018
- Shionogi Launches New Manufacturing Subsidiary, Commencing Operations in April Next Year
October 18, 2018
- Eisai’s Insomnia Treatment Lemborexant Smashes Primary Target in Long-Term PIII Study
October 18, 2018
- Daiichi Sankyo Files Quizartinib for AML in Japan
October 18, 2018
- JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
October 17, 2018
- Eisai Seals Latin America Pact for Belviq
October 17, 2018
- Teva Takeda Launches Voluntary Recall for Taxotere Generics
October 17, 2018
- Chugai’s Satralizumab Cuts Relapse Risk of Neuromyelitis Optica Spectrum Disorder
October 16, 2018
- Ono Joins GHIT Fund as 21st Funding Partner
October 16, 2018
- China Regulators Accept NDA for Fycompa
October 15, 2018
- Chugai Sues Daiichi Sankyo, Pfizer over Herceptin Biosimilars
October 15, 2018
- Oncodesign Strengthens Its Cooperation with Eisai
October 15, 2018
- Kyorin Begins Collaborative Research on Antibiotics with Microbial Chemistry Research Foundation
October 12, 2018
- Nippon Shinyaku to Expand Contract Manufacturing Biz with New Facility to Start Full Operation in Feb.
October 12, 2018
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
